Literature DB >> 22870570

Cholesterol, lipoproteins, and breast cancer risk in African American women.

Adana A Llanos1, Kepher H Makambi, Cynthia A Tucker, Sherrie Flynt Wallington, Peter G Shields, Lucile L Adams-Campbell.   

Abstract

BACKGROUND: Lipid levels, including high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides, have been reported to be associated with breast cancer risk.
METHODS: We studied African American women (97 breast cancer cases and 102 controls) accrued through a population-based, case-control study in the Washington, DC metropolitan area during 1997 and 1998. Plasma lipid levels were measured using enzymatic methods. Logistic regressions (adjusted for age, age at menarche, parity, previous alcohol consumption, and education) were used to explore the associations between lipid levels and breast cancer.
RESULTS: Through multivariable-adjusted regression, we observed a significant inverse association between breast cancer risk and increasing levels of total cholesterol (OR=.46, 95% Cl = .25-.85) and LDL (OR = .41, 95% CI = .21-.81), whereas lower levels of HDL were associated with a significant increase in risk (OR = 1.99, 95% CI = 1.06-3.74).
CONCLUSIONS: Our data demonstrate significant reductions in breast cancer risk with high levels of total cholesterol and significant increase in risk when HDL levels are low. These data are in support of a protective effect of cholesterol which has been reported in other populations; further, these findings add to the literature in an understudied population, African American women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22870570      PMCID: PMC3830419     

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  42 in total

1.  Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.

Authors:  Yu-Sen Peng; Yen-Ling Chiu; Hung-Yuan Chen; Ju-Yeh Yang; Chun-Fu Lai; Shih-Ping Hsu; Mei-Fen Pai
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

2.  HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France.

Authors:  M Ferraroni; M Gerber; A Decarli; S Richardson; E Marubini; P Crastes de Paulet; A Crastes de Paulet; H Pujol
Journal:  Int J Epidemiol       Date:  1993-10       Impact factor: 7.196

3.  Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study.

Authors:  Anne-Sofie Furberg; Grazyna Jasienska; Nils Bjurstam; Peter A Torjesen; Aina Emaus; Susan F Lipson; Peter T Ellison; Inger Thune
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

4.  Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.

Authors:  Harriet Johansson; Laura Baglietto; Aliana Guerrieri-Gonzaga; Bernardo Bonanni; Frederique Mariette; Debora Macis; Davide Serrano; Maria Teresa Sandri; Andrea Decensi
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

5.  Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease.

Authors:  M R Wrensch; N L Petrakis; L D Gruenke; R Miike; V L Ernster; E B King; W W Hauck; J C Craig; W H Goodson
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

6.  Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women.

Authors:  A P Høyer; G Engholm
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

7.  Insulin-like growth factor-binding protein-3 and breast cancer survival.

Authors:  H Yu; M A Levesque; M J Khosravi; A Papanastasiou-Diamandi; G M Clark; E P Diamandis
Journal:  Int J Cancer       Date:  1998-12-18       Impact factor: 7.396

8.  Cholesterol epoxide is a direct-acting mutagen.

Authors:  A Sevanian; A R Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.

Authors:  P G Moorman; B S Hulka; R A Hiatt; N Krieger; B Newman; J H Vogelman; N Orentreich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-06       Impact factor: 4.254

10.  Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women.

Authors:  M Gaard; S Tretli; P Urdal
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

View more
  13 in total

Review 1.  Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis.

Authors:  Jayson V Pagaduan; Vishal Sahore; Adam T Woolley
Journal:  Anal Bioanal Chem       Date:  2015-04-09       Impact factor: 4.142

2.  A Screening Study of Potential Carcinogen Biomarkers After Surgical Treatment of Obesity.

Authors:  Luciana Teixeira de Siqueira; Marcela Silvestre Outtes Wanderley; Roberto Afonso da Silva; Adriana da Silva Andrade Pereira; José Luiz de Lima Filho; Álvaro Antônio Bandeira Ferraz
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

3.  The Valuable Role of Measuring Serum Lipid Profile in Cancer Progression.

Authors:  Farahnaz Ghahremanfard; Majid Mirmohammadkhani; Banafsheh Shahnazari; Golnaz Gholami; Jamileh Mehdizadeh
Journal:  Oman Med J       Date:  2015-09

4.  The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women.

Authors:  Parisa Tehranifar; Angeline Protacio; Karen M Schmitt; Elise Desperito; Sabine Oskar; Alan J Potter; Natalie J Engmann; Mary Beth Terry
Journal:  Cancer Causes Control       Date:  2015-07-14       Impact factor: 2.506

5.  Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study.

Authors:  Anjali Gupta; Veeral Saraiya; April Deveaux; Taofik Oyekunle; Klarissa D Jackson; Omolola Salako; Adetola Daramola; Allison Hall; Olusegun Alatise; Gabriel Ogun; Adewale Adeniyi; Omobolaji Ayandipo; Thomas Olajide; Olalekan Olasehinde; Olukayode Arowolo; Adewale Adisa; Oludolapo Afuwape; Aralola Olusanya; Aderemi Adegoke; Trygve O Tollefsbol; Donna Arnett; Michael J Muehlbauer; Christopher B Newgard; Tomi Akinyemiju
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

6.  Patterns of chronic disease management and health outcomes in a population-based cohort of Black women with breast cancer.

Authors:  Michelle Doose; Jennifer Tsui; Michael B Steinberg; Cathleen Y Xing; Yong Lin; Joel C Cantor; Chi-Chen Hong; Kitaw Demissie; Elisa V Bandera
Journal:  Cancer Causes Control       Date:  2021-01-06       Impact factor: 2.506

7.  Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy.

Authors:  Xin Li; Zi-Li Liu; Yu-Tuan Wu; He Wu; Wei Dai; Bilal Arshad; Zhou Xu; Hao Li; Kai-Nan Wu; Ling-Quan Kong
Journal:  Lipids Health Dis       Date:  2018-04-20       Impact factor: 3.876

Review 8.  Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.

Authors:  Kush K Patel; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2021-06-12       Impact factor: 5.858

Review 9.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

10.  Could Anthropometric and Lipid Parameters Reflect Susceptibility to Breast Cancer? Comparison of Newly Diagnosed Breast Cancer and Apparently Healthy Women

Authors:  H M K Akalanka; S Ekanayake; K Samarasinghe
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.